James W. Black

GPTKB entity

Statements (55)
Predicate Object
gptkbp:instance_of gptkb:pharmaceuticals
gptkbp:affiliation gptkb:Glaxo_Smith_Kline
gptkb:Smith_Kline_Beecham
gptkbp:alma_mater gptkb:University_of_St_Andrews
gptkb:University_of_Edinburgh
gptkbp:awards gptkb:Nobel_Prize_in_Physiology_or_Medicine
gptkbp:birth_date 1924-06-14
gptkbp:birth_place gptkb:Bristol,_England
gptkbp:children gptkb:3
gptkbp:contribution improved treatment for heart conditions
improved treatment for ulcers
gptkbp:death_date 2010-03-22
gptkbp:death_place gptkb:London,_England
gptkbp:field gptkb:Medicine
pharmacology
https://www.w3.org/2000/01/rdf-schema#label James W. Black
gptkbp:influence gptkb:Health_Insurance
patient safety
therapeutic drug monitoring
clinical trials
research funding
medical education
evidence-based medicine
medical ethics
clinical pharmacology
drug regulation
pharmaceutical industry practices
modern pharmacology
cardiovascular therapy
gastrointestinal therapy
gptkbp:influenced cardiology
drug development
gastroenterology
gptkbp:invention gptkb:ranitidine
gptkb:atenolol
gptkb:metoprolol
gptkb:cimetidine
propranolol
gptkbp:known_for pharmaceutical innovations
development of propranolol
clinical applications of H2-receptor antagonists
clinical applications of beta-blockers
development of cimetidine
gptkbp:legacy impact on patient care
impact on medical research
impact on drug design
gptkbp:nationality gptkb:British
gptkbp:occupation gptkb:Inventor
gptkb:Scientist
gptkbp:research_focus beta-blockers
H2-receptor antagonists
gptkbp:residence gptkb:United_Kingdom
gptkbp:spouse Margaret Black
gptkbp:bfsParent gptkb:University_of_Wisconsin
gptkbp:bfsLayer 5